🇺🇸 FDA
Patent

US 6329357

Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases

expired A61KA61K31/575A61K31/59

Quick answer

US patent 6329357 (Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases) held by The Regents of the University of California expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/575, A61K31/59